AI Advances Vaccine Development for Evolving Viruses, Aims for Broad Protection
Rapid Read

AI Advances Vaccine Development for Evolving Viruses, Aims for Broad Protection

What's Happening? Researchers at DIOSynVax, led by Professor Jonathan Heeney of the University of Cambridge, are utilizing artificial intelligence (AI) to design novel vaccine antigens. This approach aims to create broadly protective vaccines that can target rapidly evolving RNA viruses like influen
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.